» Authors » Ken-ichiro Katsura

Ken-ichiro Katsura

Explore the profile of Ken-ichiro Katsura including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 43
Citations 1215
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nomura K, Mishina M, Okubo S, Suda S, Katsura K, Katayama Y
J Nippon Med Sch . 2015 Mar; 82(1):68-72. PMID: 25797880
A 33-year-old man presented with a lateral medullary infarction, vertigo, and nausea. At the time of hospital admission, he had Wallenberg syndrome. Although initial magnetic resonance imaging showed no abnormalities,...
2.
Kanamaru T, Kamimura N, Yokota T, Nishimaki K, Iuchi K, Lee H, et al.
Brain Res . 2015 Feb; 1605:49-58. PMID: 25698614
Stem cell transplantation therapy is currently in clinical trials for the treatment of ischemic stroke, and several beneficial aspects have been reported. Similarly, in Alzheimer's disease (AD), stem cell therapy...
3.
Kanamaru T, Kamimura N, Yokota T, Iuchi K, Nishimaki K, Takami S, et al.
Neurosci Lett . 2014 Dec; 587:126-31. PMID: 25529196
Oxidative stress is known to play a prominent role in the onset and early stage progression of Alzheimer's disease (AD). For example, protein oxidation and lipid peroxidation levels are increased...
4.
Abe A, Okubo S, Onozawa S, Nakajima M, Suzuki K, Harada-Abe M, et al.
Interv Neuroradiol . 2014 Jul; 20(3):325-8. PMID: 24976095
Few reports have described the successful treatment of stroke caused by acute vertebral artery (VA) origin occlusion by endovascular surgery. We describe the case of a 68-year-old man who experienced...
5.
Abe A, Harada-Abe M, Ueda M, Katano T, Nakajima M, Muraga K, et al.
Cerebrovasc Dis Extra . 2014 Jun; 4(2):92-101. PMID: 24926306
Background: Cerebral infarction of unknown origin at admission accounts for half of all cerebral infarction cases in some institutions. However, the factors associated with cerebral infarction prognosis have not been...
6.
Toda Y, Katsura K, Saito M, Inaba T, Sakurazawa M, Katayama Y
Neurol Res . 2014 May; 36(11):1011-9. PMID: 24836463
Objectives: Among several anti-platelet drugs to prevent recurrent stroke, cilostazol has shown various effects besides its anti-platelet activity. We examined whether 7 days of oral administration of cilostazol protects against...
7.
Nakajima M, Abe A, Nishiyama Y, Harada-Abe M, Kutsuna A, Goto Y, et al.
Case Rep Neurol . 2013 Dec; 5(3):195-200. PMID: 24348399
A 39-year-old man with a history of rupture of a sinus of Valsalva aneurysm experienced an ischemic stroke. Although the patient presented left-sided hemiparesis for a week, no abnormal signals...
8.
Saito T, Nito C, Ueda M, Inaba T, Kamiya F, Muraga K, et al.
Life Sci . 2013 Dec; 94(2):106-14. PMID: 24333133
Aims: Pre-treatment with statins is known to ameliorate ischemic brain damage after experimental stroke, and is independent of cholesterol levels. We undertook pre- vs post-ischemic treatment with atorvastatin after focal...
9.
Suda S, Katsumata T, Okubo S, Kanamaru T, Suzuki K, Watanabe Y, et al.
Cerebrovasc Dis . 2013 Nov; 36(5-6):388-93. PMID: 24248098
Background: Epidemiological and clinical trials have shown that n-3 polyunsaturated fatty acids (PUFAs) reduce the incidence of coronary heart disease or stroke. However, the association between PUFAs and acute-phase stroke...
10.
Suda S, Katsura K, Okubo S, Abe A, Suzuki K, Suzuki M, et al.
J Stroke Cerebrovasc Dis . 2013 Aug; 22(8):e684-6. PMID: 23938340
Thromboembolic complications, such as deep venous thrombosis and pulmonary embolism, are well described in patients with inflammatory bowel disease, but cerebral venous thrombosis (CVT) is a rare but potentially devastating...